Health ❯ Healthcare

Drug Development

Clinical Trials Clinical Research Regulatory Affairs FDA Approval Regulatory Approval Pharmaceuticals Therapeutics Efficacy Studies Biopharmaceuticals Combination Therapy

3 ARTICLES

last wk.

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

The agreement pools drug supply, shares trial costs, preserves each company’s commercial rights, launching a Phase III first‑line triple‑negative breast cancer study

3 ARTICLES

last wk.

Mitochondrial Map and Reannotated Genome Reveal How Acanthamoeba Survives Low Oxygen

3 ARTICLES

last wk.

Foghorn Therapeutics Ends Lilly Partnership, Stops SMARCA2 Program and Cuts 40% of Staff

8 ARTICLES

2w ago

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

6 ARTICLES

2w ago

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

3 ARTICLES

2w ago

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

5 ARTICLES

3w ago

Viking’s VK2735 Shows Durable Weight Loss With Less‑Frequent Dosing

5 ARTICLES

3w ago

Stanford’s 37,000‑Agent 'Virtual Biotech' Finds Trial‑Success Signal and Designs Lung‑Cancer Therapy

4 ARTICLES

4w ago

Teva’s Experimental Antibody Prevents Gluten‑Triggered Intestinal Damage in Mid‑Stage Celiac Trial

8 ARTICLES

last mo.

Anvisa Registers Yluméc, EMS Semaglutide Pen for Type 2 Diabetes

3 ARTICLES

last mo.

Pacibekitug Cuts hs-CRP by Up to 89% in Phase II Kidney Disease Trial

6 ARTICLES

last mo.

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

9 ARTICLES

last mo.

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

56 ARTICLES

last mo.

FDA Clears First Broadly RAS‑Targeting Pill for Advanced Pancreatic Cancer

3 ARTICLES

last mo.

FDA Approves Bixlenvo, a Once‑Daily Single‑Pill HIV Regimen

3 ARTICLES

last mo.

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma mRNA Vaccine

Drug Development

AstraZeneca, Daiichi Sankyo and Summit Launch Global Trials of Datroway With Ivonescimab

Mitochondrial Map and Reannotated Genome Reveal How Acanthamoeba Survives Low Oxygen

Foghorn Therapeutics Ends Lilly Partnership, Stops SMARCA2 Program and Cuts 40% of Staff

AstraZeneca Buys Stake in Summit to Pursue Cancer Drug Combinations

Kodiak Drugs Clear Phase 3 for Wet AMD and Shares Soar

aTyr Pharma Secures FDA Agreement on Phase 3 Protocol for Efzofitimod in Pulmonary Sarcoidosis

Viking’s VK2735 Shows Durable Weight Loss With Less‑Frequent Dosing

Stanford’s 37,000‑Agent 'Virtual Biotech' Finds Trial‑Success Signal and Designs Lung‑Cancer Therapy

Gotistobart Extends Survival in Early PRESERVE‑003 Update

AstraZeneca’s Etcamah Falls Short in Pivotal SERENA‑4 Breast Cancer Trial

Never miss stories about

Drug Development

FDA Approves Camizestrant for ESR1‑Mutated Advanced Breast Cancer

AstraZeneca's Tozorakimab Cuts COPD Flare‑Ups in Two Phase 3 Trials

Teva’s Experimental Antibody Prevents Gluten‑Triggered Intestinal Damage in Mid‑Stage Celiac Trial

Anvisa Registers Yluméc, EMS Semaglutide Pen for Type 2 Diabetes

Pacibekitug Cuts hs-CRP by Up to 89% in Phase II Kidney Disease Trial

Aficamten Improves Symptoms and Exercise Capacity in Nonobstructive HCM

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

FDA Clears First Broadly RAS‑Targeting Pill for Advanced Pancreatic Cancer

FDA Approves Bixlenvo, a Once‑Daily Single‑Pill HIV Regimen

Moderna and Merck Report Positive Phase 3 Results for Personalized Melanoma mRNA Vaccine

Never miss stories about

Drug Development